Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 24468417)

1.

Comparison of the prevalence, clinical features, and long-term outcomes of midventricular hypertrophy vs apical phenotype in patients with hypertrophic cardiomyopathy.

Cai C, Duan FJ, Yang YJ, Guo XY, Liu YL, Liu YQ, Yan LR, Xu ZM, Zhao SH, Hua W, Li YS, Fan CM.

Can J Cardiol. 2014 Apr;30(4):441-7. doi: 10.1016/j.cjca.2013.10.005. Epub 2013 Oct 9.

PMID:
24468417
2.

Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.

Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ.

Circulation. 2008 Oct 7;118(15):1541-9. doi: 10.1161/CIRCULATIONAHA.108.781401. Epub 2008 Sep 22.

3.

Clinical features and outcome of patients with apical hypertrophic cardiomyopathy in Taiwan.

Lee CH, Liu PY, Lin LJ, Chen JH, Tsai LM.

Cardiology. 2006;106(1):29-35. Epub 2006 Apr 7.

PMID:
16612066
5.

Coronary flow reserve impairment in apical vs asymmetrical septal hypertrophic cardiomyopathy.

Ahn HS, Kim HK, Park EA, Lee W, Kim YJ, Cho GY, Park JH, Sohn DW.

Clin Cardiol. 2013 Apr;36(4):207-16. doi: 10.1002/clc.22095. Epub 2013 Feb 3.

PMID:
23378014
6.

Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.

Olivotto I, Maron BJ, Tomberli B, Appelbaum E, Salton C, Haas TS, Gibson CM, Nistri S, Servettini E, Chan RH, Udelson JE, Lesser JR, Cecchi F, Manning WJ, Maron MS.

J Am Coll Cardiol. 2013 Jul 30;62(5):449-57. doi: 10.1016/j.jacc.2013.03.062. Epub 2013 Apr 30.

7.

Clinical characteristics and outcomes of hypertrophic cardiomyopathy in Taiwan--a tertiary center experience.

Lee CH, Liu PY, Lin LJ, Chen JH, Tsai LM.

Clin Cardiol. 2007 Apr;30(4):177-82.

PMID:
17443650
8.

Hypertrophic cardiomyopathy in Greece: clinical course and outcome.

Kyriakidis M, Triposkiadis F, Anastasakis A, Theopistou A, Tocta R, Barbetseas J, Gialafos J.

Chest. 1998 Oct;114(4):1091-6.

PMID:
9792582
9.

Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment.

Ball W, Ivanov J, Rakowski H, Wigle ED, Linghorne M, Ralph-Edwards A, Williams WG, Schwartz L, Guttman A, Woo A.

J Am Coll Cardiol. 2011 Nov 22;58(22):2313-21. doi: 10.1016/j.jacc.2011.08.040.

10.

Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.

Gruner C, Chan RH, Crean A, Rakowski H, Rowin EJ, Care M, Deva D, Williams L, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Siminovitch K, Ralph-Edwards AC, Rastegar H, Maron BJ, Maron MS.

Eur Heart J. 2014 Oct 14;35(39):2706-13. doi: 10.1093/eurheartj/ehu154. Epub 2014 May 8.

PMID:
24810389
11.

Long-term outcome in patients with apical hypertrophic cardiomyopathy.

Eriksson MJ, Sonnenberg B, Woo A, Rakowski P, Parker TG, Wigle ED, Rakowski H.

J Am Coll Cardiol. 2002 Feb 20;39(4):638-45.

PMID:
11849863
12.

Doppler echocardiographic evaluation of midventricular obstruction in cats with hypertrophic cardiomyopathy.

MacLea HB, Boon JA, Bright JM.

J Vet Intern Med. 2013 Nov-Dec;27(6):1416-20. doi: 10.1111/jvim.12175. Epub 2013 Sep 3.

PMID:
24001306
13.

Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy.

Maron MS, Rowin EJ, Lin D, Appelbaum E, Chan RH, Gibson CM, Lesser JR, Lindberg J, Haas TS, Udelson JE, Manning WJ, Maron BJ.

Circ Cardiovasc Imaging. 2012 Jul;5(4):441-7. doi: 10.1161/CIRCIMAGING.112.972760. Epub 2012 May 4.

14.

Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.

Kubo T, Gimeno JR, Bahl A, Steffensen U, Steffensen M, Osman E, Thaman R, Mogensen J, Elliott PM, Doi Y, McKenna WJ.

J Am Coll Cardiol. 2007 Jun 26;49(25):2419-26. Epub 2007 Jun 11.

15.

[Hypertrophic cardiomyopathy (HCM). Surgical versus drug therapy].

Schulte HD, Gramsch-Zabel H, Schwartzkopff B, Gams E.

Z Kardiol. 1999 Mar;88(3):163-72. Review. German.

PMID:
10355066
16.

[Assessment of pathophysiology based on the left ventricular shape in five patients with midventricular obstructive hypertrophic cardiomyopathy].

Aoki M, Uekita K, Obata H, Makiguchi N, Mitsuoka T, Kikuchi K.

J Cardiol. 2007 Jul;50(1):29-38. Japanese.

PMID:
17685027
17.

Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy.

Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ.

Circulation. 2006 Jul 18;114(3):216-25. Epub 2006 Jul 10.

18.

Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.

Olivotto I, Maron MS, Adabag AS, Casey SA, Vargiu D, Link MS, Udelson JE, Cecchi F, Maron BJ.

J Am Coll Cardiol. 2005 Aug 2;46(3):480-7.

19.

Clinical profiles of hypertrophic cardiomyopathy with apical phenotype--comparison of pure-apical form and distal-dominant form.

Kubo T, Kitaoka H, Okawa M, Hirota T, Hoshikawa E, Hayato K, Yamasaki N, Matsumura Y, Yabe T, Nishinaga M, Takata J, Doi YL.

Circ J. 2009 Dec;73(12):2330-6. Epub 2009 Oct 17.

20.

Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with "pure" apical hypertrophic cardiomyopathy.

Kim KH, Kim HK, Hwang IC, Lee SP, Park EA, Lee W, Kim YJ, Park JH, Sohn DW.

J Cardiovasc Magn Reson. 2012 Jul 28;14:52. doi: 10.1186/1532-429X-14-52.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk